Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intra-nanoparticle Drug-protein Interactions Mediate Sequential Therapeutic Release.

bioRxiv : the preprint server for biology·2026

Same author

Preparation of High Foliar Adhesion Disulfide-Functionalized Yeast Microcapsules for Targeted Pesticide Release.

ACS applied materials & interfaces·2026

Same author

Synergistic design of ionic liquid monomers and MOF-cellulose scaffolds for selective protein recognition in molecularly imprinted materials.

Carbohydrate polymers·2026

Same author

Photo-crosslinked hyaluronic acid-based hydrogels for <i>in vitro</i> drug delivery.

Journal of biomaterials science. Polymer edition·2026

Same author

Technology for Nucleic Acid Delivery in the Treatment of Hematological Malignancies.

Advanced drug delivery reviews·2026

Same author

Corrigendum to "Paper-roll-pencils inspired self-assembled multilayer interwoven nanocellulose supercapacitor electrode enables cross-scale stress impedance coupled with electrochemical stability" [Carbohydrate Polymers 368 (2025) 124165].

Carbohydrate polymers·2025

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

Nanoparticulate systems for growth factor delivery.

Sufeng Zhang¹, Hasan Uludağ

¹Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, #830, Chemical & Materials Engineering Building, Edmonton, Alberta T6G2G6, Canada.

Pharmaceutical Research

|May 6, 2009

Summary

Nanoparticulate delivery systems offer advanced methods for administering growth factors, improving therapeutic outcomes in tissue engineering. These systems enhance drug delivery for applications in bone, skin, and nerve regeneration.

More Related Videos

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Published on: August 16, 2014

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

Related Experiment Videos

Last Updated: Jun 23, 2026

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Published on: August 16, 2014

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

Area of Science:

Nanotechnology
Pharmaceutical Sciences
Biotechnology

Background:

Nanotechnology enables precise control over matter at the 1-100 nm scale, significantly impacting pharmaceutical development.
Growth factors, crucial for cellular activities, are promising therapeutics for tissue engineering but face challenges like rapid degradation and non-specific distribution.
Nanoparticulate delivery systems are emerging as a solution to overcome growth factor delivery limitations.

Purpose of the Study:

To review recent advancements in nanoparticulate systems for effective growth factor delivery.
To discuss the therapeutic applications of growth factors delivered via nanoparticulate systems, focusing on tissue regeneration and angiogenesis.
To highlight current limitations and future directions in the field of growth factor-loaded nanoparticulate delivery.

Main Methods:

Review of current literature on nanoparticulate delivery systems for growth factors.
Analysis of various nanoparticulate system designs and their efficacy in protecting and delivering growth factors.
Examination of therapeutic outcomes in preclinical and clinical studies involving growth factor delivery systems.

Main Results:

Nanoparticulate systems demonstrate potential for controlled release, prolonged circulation, and targeted delivery of growth factors.
These systems have shown promise in promoting bone, skin, and nerve regeneration, as well as angiogenesis.
Various nanoparticulate formulations offer distinct advantages and disadvantages for growth factor delivery.

Conclusions:

Nanoparticulate delivery systems are crucial for overcoming the inherent challenges of growth factor therapeutics.
Effective delivery is key to realizing the full potential of growth factors in tissue engineering and regenerative medicine.
Further research is needed to address current limitations and optimize nanoparticulate systems for clinical translation.